세계의 유전체학 AI 시장 보고서(2025년)

AI in genomics refers to a collection of computer tools utilized by genomics researchers to handle and decipher critical information embedded in large datasets generated from DNA sequencing and other biological processes. These algorithms are designed to identify patterns and abnormalities within genomic data, aiding researchers in understanding the complexities of the human genome.

The main components involved in AI in genomics include hardware, software, and services, with machine learning and computer vision as the key technologies. Hardware encompasses both external and internal components and equipment that enable users to perform various operations such as input, output, storage, communication, and processing. The main functionalities of AI in genomics include genome sequencing, gene editing, and others, and these technologies find applications in diverse areas, including drug discovery and development, precision medicine, diagnostics, and more. The major end-users of AI in genomics include pharmaceutical and biotech companies, healthcare providers, research centers, and other entities involved in genomics research.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The AI in genomics market research report is one of a series of new reports from The Business Research Company that provides AI in genomics market statistics, including AI in genomics industry global market size, regional shares, competitors with an AI in genomics market share, detailed AI in genomics market segments, market trends and opportunities, and any further data you may need to thrive in the AI in genomics industry. This AI in genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in genomics market size has grown exponentially in recent years. It will grow from $1.06 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 41.9%. The growth in the historic period can be attributed to advancements in genomic sequencing, data handling challenges, personalized medicine demand, disease understanding and diagnosis, drug discovery and development.

The ai in genomics market size is expected to see exponential growth in the next few years. It will grow to $6.52 billion in 2029 at a compound annual growth rate (CAGR) of 44.2%. The growth in the forecast period can be attributed to expansion of genomic databases, enhanced genomic data security, AI-driven biomarker discovery, integration with other 'omics' data, patient empowerment and education. Major trends in the forecast period include AI in cancer genomics, AI-enhanced genomic imaging, AI-driven biomarker discovery, genomic data integration across healthcare systems, AI in functional genomics research.

The forecast of 44.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by raising costs for AI-powered gene sequencing tools, reliant on specialized hardware from Switzerland and Japan, slowing medical research advancements. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing adoption of AI is anticipated to drive the growth of the AI in genomics market in the future. Artificial intelligence (AI) refers to a field that utilizes computer science and extensive datasets to address various challenges. It encompasses subfields such as machine learning and deep learning, which are frequently mentioned in discussions surrounding artificial intelligence. In genomics, AI aids in identifying genetic disorders and major cancer types, predicting the progression of specific diseases in patients, pinpointing genomic variations that cause diseases, and enhancing the capabilities of gene editing tools. As a result of these advantages, there is a rising demand for AI in genomics. For example, a report from International Business Machines Corporation (IBM) published in May 2022 revealed that the global adoption rate of AI surged to 35%, representing a four percent increase from the previous year. Additionally, a report released in May 2023 by the Commonwealth Scientific and Industrial Research Organization (CSIRO), an Australian government agency, indicated that 68% of businesses in Australia had already implemented AI technologies, with another 23% planning to adopt them within the coming year. Therefore, the growing adoption of AI is significantly contributing to the expansion of the AI in genomics market.

The escalating adoption of personalized medicine methodologies is projected to propel the advancement of the AI in genomics market in the forthcoming years. Personalized medicine, also known as precision medicine, represents an innovative approach to healthcare that considers individual variations in genes, environments, and lifestyles when tailoring medical treatments. The integration of AI in genomics for personalized medicine not only augments the speed and precision of genetic analyses but also paves the way for customizing medical interventions for individual patients, thereby enhancing treatment outcomes and advancing precision medicine. For instance, in February 2023, the Personalized Medicine Coalition disclosed that personalized pharmaceuticals accounted for 34% of new medications approved by the US Food and Drug Administration in 2022, maintaining a consistent trend of comprising at least 25% of approvals over the past eight years. Therefore, the increasing utilization of personalized medicine strategies acts as a catalyst for the growth of the AI in genomics market.

Technological advancements constitute a significant and growing trend within the AI in genomics market. Prominent industry players are intensely focused on developing innovative technological solutions to bolster their market standing. For example, in March 2023, Genomic Vision, a France-based biotechnology firm specializing in diagnostic solutions for genetic diseases and cancers, unveiled FiberSmart, an AI-powered software designed for the visualization and high-resolution analysis of lengthy DNA fibers. This groundbreaking technology has the potential to revolutionize the diagnosis and treatment of genetic disorders by enhancing precision and efficacy in diagnosis and treatment. The software analyzes substantial volumes of data to unveil patterns and insights that would otherwise be beyond human capacity to discern independently.

Major players within the AI in genomics market are strategically pursuing partnerships to elevate patient care standards. Strategic partnerships involve companies leveraging each other's strengths and resources to attain mutual advantages and bolster success. For instance, in March 2022, the International Business Machines Corporation (IBM), a prominent US-based technology firm, unveiled a partnership with Genomics England. This collaboration entails IBM working with Genomics England across three key domains such as enhancing the clinical user interface, facilitating swift access to genetic data storage, integrating cloud capabilities within a hybrid cloud environment, and managing services. Genomics England, a UK-based government entity, oversees the 100,000 Genomes Project.

In May 2022, Sema4 Inc., a US-based AI-powered genomic and clinical data intelligence platform company, acquired GeneDx LLC for an approximate sum of $623 million. This strategic acquisition positions Sema4 as one of the foremost and most advanced providers of genomic testing in the United States. Moreover, it fortifies their health information repository, aiming to revolutionize patient care and augment advancements in therapeutic development. This acquisition further expedites Sema4's ability to deliver precision medicine while optimizing platform efficiency. GeneDx LLC, a US-based entity specializing in genetics and genomics, offers AI-enabled testing services to patients, aligning well with Sema4's objectives.

Major companies operating in the AI in genomics market include International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Lifebit Biotech Ltd., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., Genomenon Inc.

North America was the largest region in the AI in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in the ai in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ai in genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in genomics market includes revenues earned by entities by providing services such as computer vision, time series analysis, automatic speech recognition, and natural language processing. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in genomics market also includes sales of neural network hardware, powered diagnostics and imaging machine which are used in providing AI in genomics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Technology: Machine Learning; Computer Vision
• 3) By Functionality: Genome Sequencing; Gene Editing; Other Functionalities
• 4) By Application: Drug Discovery And Development; Precision Medicine; Diagnostics; Other Applications
• 5) By End-Use: Pharmaceutical And Biotech Companies; Healthcare Providers; Research Centers; Other End-Users
• Subsegments:
• 1) By Hardware: Servers; Storage Devices; Networking Equipment
• 2) By Software: Data Analysis Software; Machine Learning Algorithms; Visualization Tools; Genomic Data Management Software
• 3) By Services: Consulting Services; Integration Services; Support And Maintenance; Data Analytics Services
• Companies Mentioned: International Business Machines Corporation; Microsoft Corp.; NVIDIA Corporation; Deep Genomics Inc.; BenevolentAI Ltd.; Fabric Genomics Inc.; Verge Genomic Inc.; Freenome Holdings Inc.; MolecularMatch Inc.; SOPHiA GENETICS SA; Data4Cure Inc.; PrecisionLife Ltd.; Genoox Ltd.; Lifebit Ltd.; Empiric Logic Ltd.; FDNA Inc.; DNAnexus Inc.; Engine Biosciences Pte Ltd.; 4baseCare; Congenica Ltd.; CytoReason Ltd.; Emedgene Technologies LTD; Illumina Inc.; Lifebit Biotech Ltd.; Mendel.ai; Predictive Oncology Inc.; Tempus Labs Inc.; 10x Genomics Inc.; Repositive Limited; Genedata AG; Global Gene Corp; Nference Inc.; Bluebee Holding B.V.; Genomenon Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Genomics Market Characteristics

3. AI In Genomics Market Trends And Strategies

4. AI In Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global AI In Genomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Genomics Market Growth Rate Analysis
• 5.4. Global AI In Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Genomics Total Addressable Market (TAM)

6. AI In Genomics Market Segmentation

• 6.1. Global AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Machine Learning
• Computer Vision
• 6.3. Global AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genome Sequencing
• Gene Editing
• Other Functionalities
• 6.4. Global AI In Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Precision Medicine
• Diagnostics
• Other Applications
• 6.5. Global AI In Genomics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotech Companies
• Healthcare Providers
• Research Centers
• Other End-Users
• 6.6. Global AI In Genomics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Servers
• Storage Devices
• Networking Equipment
• 6.7. Global AI In Genomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Machine Learning Algorithms
• Visualization Tools
• Genomic Data Management Software
• 6.8. Global AI In Genomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Integration Services
• Support And Maintenance
• Data Analytics Services

7. AI In Genomics Market Regional And Country Analysis

• 7.1. Global AI In Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Genomics Market

• 8.1. Asia-Pacific AI In Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Genomics Market

• 9.1. China AI In Genomics Market Overview
• 9.2. China AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Genomics Market

• 10.1. India AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Genomics Market

• 11.1. Japan AI In Genomics Market Overview
• 11.2. Japan AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Genomics Market

• 12.1. Australia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Genomics Market

• 13.1. Indonesia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Genomics Market

• 14.1. South Korea AI In Genomics Market Overview
• 14.2. South Korea AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Genomics Market

• 15.1. Western Europe AI In Genomics Market Overview
• 15.2. Western Europe AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Genomics Market

• 16.1. UK AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Genomics Market

• 17.1. Germany AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Genomics Market

• 18.1. France AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Genomics Market

• 19.1. Italy AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Genomics Market

• 20.1. Spain AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Genomics Market

• 21.1. Eastern Europe AI In Genomics Market Overview
• 21.2. Eastern Europe AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Genomics Market

• 22.1. Russia AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Genomics Market

• 23.1. North America AI In Genomics Market Overview
• 23.2. North America AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Genomics Market

• 24.1. USA AI In Genomics Market Overview
• 24.2. USA AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Genomics Market

• 25.1. Canada AI In Genomics Market Overview
• 25.2. Canada AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Genomics Market

• 26.1. South America AI In Genomics Market Overview
• 26.2. South America AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Genomics Market

• 27.1. Brazil AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Genomics Market

• 28.1. Middle East AI In Genomics Market Overview
• 28.2. Middle East AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Genomics Market

• 29.1. Africa AI In Genomics Market Overview
• 29.2. Africa AI In Genomics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Genomics Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Genomics Market Competitive Landscape And Company Profiles

• 30.1. AI In Genomics Market Competitive Landscape
• 30.2. AI In Genomics Market Company Profiles
  • 30.2.1. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Microsoft Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Deep Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BenevolentAI Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. AI In Genomics Market Other Major And Innovative Companies

• 31.1. Fabric Genomics Inc.
• 31.2. Verge Genomic Inc.
• 31.3. Freenome Holdings Inc.
• 31.4. MolecularMatch Inc.
• 31.5. SOPHiA GENETICS SA
• 31.6. Data4Cure Inc.
• 31.7. PrecisionLife Ltd.
• 31.8. Genoox Ltd.
• 31.9. Lifebit Ltd.
• 31.10. Empiric Logic Ltd.
• 31.11. FDNA Inc.
• 31.12. DNAnexus Inc.
• 31.13. Engine Biosciences Pte Ltd.
• 31.14. 4baseCare
• 31.15. Congenica Ltd.

32. Global AI In Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Genomics Market

34. Recent Developments In The AI In Genomics Market

35. AI In Genomics Market High Potential Countries, Segments and Strategies

• 35.1 AI In Genomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Genomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Genomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer